• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
3 results

Eli Lilly and Company v. Teva Pharmaceuticals

Docket 20-1876, U.S. Court of Appeals, Federal Circuit (June 11, 2020)
Appellant ELI LILLY AND COMPANY
Appellee TEVA PHARMACEUTICALS INTERNATIONAL GMBH
cite Cite Docket
Analyze

OPINION filed for the court by Lourie, Circuit Judge; Bryson, Circuit Judge and O'Malley, Circuit ...

Document ELI LILLY AND COMPANY v. TEVA PHARMACEUTICALS, 20-1876 (Fed. Cir. Aug. 16, 2021)
Axiomatically, without an individual experi- encing vasomotor symptoms, there would be no effective amount that could be used to treat the nonexistent symp- toms.
cite Cite Document
Analyze

No. 25 MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Eli Lilly and Company

Document Eli Lilly and Company v. Teva Pharmaceuticals, 20-1876, No. 25 (Fed. Cir. Nov. 2, 2020)
None/Not Applicable 2.
None/Not Applicable 3.
None/Not Applicable Eli Lilly and Company Eli Lilly and Company 4.
None/Not Applicable Additional pages attached John Williamson Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 5.
Additional pages attached None/Not Applicable C.A. No. 1:18-cv-12029 Teva Pharm. Int’l GmbH v. Eli Lilly & Co. (D. Mass.
None/Not Applicable Additional pages attached v Case: 20-1876 Document: 25 Page: 7 Filed: 11/02/2020 TABLE OF CONTENTS Page STATEMENT OF RELATED CASES ................................................................. xiii STATEMENT ...
In its Reply, Petitioner argued that “[t]he Board invited testimony on whether such symptoms include stimulated cAMP formulation, but Teva provided none.
(5) None of the additional art Petitioner cites provides a reasonable expectation that an anti-CGRP antibody can be safely used for treating migraine in humans Patent Owner argues that “Lilly relies on Queen for a reasonable expectation of ...
cite Cite Document
Analyze
+ More Snippets

Can’t find a case you think should be here?

Use our supplemental search tool to find dockets that you may not see here. Information on Fees

Start a Supplemental Search